CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nuevolution AB (publ) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nuevolution AB (publ)
Roennegade 8
Koebenhavn, 2100  Denmark

This company is no longer actively traded on any major stock exchange.

Business Summary
Nuevolution AB is a Sweden-based biopharmaceutical company working to develop future medicine for the treatment of cancer and inflammatory diseases. The Company’s business is conducted through its wholly owned subsidiary, Nuevolution A/S.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201912/31/2018Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board StigLoekke Pedersen 56 1/1/2001 1/1/2001
Chief Executive Officer AlexHaahr Gouliaev 52 9/1/2005
Chief Financial Officer JohnnyStilou 51 8/31/2018 3/1/2018
6 additional Officers and Directors records available in full report.

Business Names
Business Name
0GCT
NUE
Nuevolution A/S

General Information
Number of Employees: 47 (As of 3/31/2019)
Outstanding Shares: 49,525,000 (As of 3/31/2019)
Shareholders: 3,219
Stock Exchange: STO


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023